Lidocaine Sans Conservateur Aguettant (Lidocaine Hydrochloride Monohydrate)

Lidocaine works by blocking voltage‑gated sodium channels on neuronal membranes, stabilising them in an inactive state. This prevents the generation and propagation of action potentials, resulting in a temporary loss of sensory and, at higher concentrations, motor nerve function in the area where it is administered.

The appropriate dose of Lidocaine Sans Conservateur Aguettant is determined by the prescribing clinician based on the specific procedure, route of administration, patient weight, age and overall health. No fixed dosing regimen is provided here; the prescriber tailors the amount to each individual case.

Safety data for lidocaine use during pregnancy and lactation are limited. The decision to use this product in pregnant or nursing patients should be made by the treating physician after evaluating potential benefits against possible risks to the mother and child.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Lidocaine and bupivacaine are both amide‑type local anesthetics. Lidocaine has a faster onset of action but a shorter duration, making it suitable for short procedures. Bupivacaine provides a longer block but has a higher risk of cardiotoxicity at elevated doses. Choice depends on the clinical need for speed versus duration of anesthesia.

Lidocaine Sans Conservateur Aguettant should be stored at room temperature, below 25 °C. Keep the vial in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly sealed to maintain sterility.

The product is supplied as a sterile solution for injection and may be administered via epidural, infiltration or intramuscular routes. Administration is performed by a qualified healthcare professional using aseptic technique, with the dose and injection site selected according to the intended clinical use.

Serious risks include allergic reactions (including anaphylaxis), cardiac arrhythmias such as ventricular tachycardia, seizures due to high plasma concentrations, methemoglobinemia, severe hypotension and respiratory depression. Prompt recognition and supportive management are essential if any of these events occur.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block, uncontrolled arrhythmias, significant hepatic impairment, or a history of methemoglobinemia should avoid using this product. Contra‑indications should be confirmed by the prescribing clinician.